Skip to main content
. 2020 Apr 20;3:180. doi: 10.1038/s42003-020-0885-5

Table 1.

Clinically relevant mutations observed in the UK10K dataset.

Genome Location (hg19) SNP ID Ref Alt No. of carriers identified QUAL score MAF (gnomAD) Functional effect DNA change Amino acid change
chr1:215956104 rs111033264 A G 1 24.8 2.889E-07 Missense c.10561T > C p.Trp3521Arg
chr1:215963510 rs148660051 C T 4 247 0.000003829 Missense c.10073G > A p.Cys3358Tyr
chr1:216019240 rs397518041 C T 1 46.4 0.00001627 Stop-Gain c.8981G> A p.Trp2994*
chr1:216420436 rs80338903 C 7 967 0.0006835 Frameshift c.2299delG p.Glu767Serfs
chr1:216497582 rs121912600 C A 1 171 0.00004079 Missense c.1256G > T p.Cys419Phe

Genome location is given in the format chr:variant position (hg19). QUAL score refers to PHRED quality score for sequence data at given base. Ref is the allele observed in the Human Reference sequence (hg19). Alt is the alternative allele observed in the UK10K. All variants were observed in a heterozygous form. Minor Allele Frequency (MAF) is given for all samples in the gnomAD population database (https://gnomad.broadinstitute.org/). DNA change refers to the position in the coding sequence for the gene. Amino acid change refers to the position altered in the protein.